The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
The Food and Drug Administration (FDA) has recalled over 7,000 bottles of the popular antidepressant duloxetine – sold under ...
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant duloxetine over the presence of ...
The FDA recalled more than 7,000 bottles of an antidepressant due to the presence of a carcinogenic chemical. The ...
Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name Cymbalta, have been recalled, the ...
The Food and Drug Administration issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to ...
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of ...
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
The recall was initiated due to the discovery of N-nitroso-duloxetine, a chemical impurity classified as a nitrosamine.
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.